Alpenglow Biosciences will be attending BioCentury Grand Rounds: U.S. 2026, taking place June 3 to 5, 2026, at the Hyatt Regency Seattle.

As part of the event, Nick Reder, MD, MPH, CEO of Alpenglow Biosciences, is scheduled to present on Thursday, June 4, 2026, at 10:20 AM.

BioCentury Grand Rounds: U.S. brings together biotechnology leaders, investors, and strategic partners for conversations around emerging companies, innovation, and the future of healthcare. Alpenglow looks forward to connecting with attendees interested in 3D digital pathology, spatial biology, whole-tissue imaging, and AI-powered tissue analysis.

Presentation details
Speaker: Nick Reder, MD, MPH
Title: CEO, Alpenglow Biosciences
Date: Thursday, June 4, 2026
Time: 10:20 AM
Location: Hyatt Regency Seattle
Event: 3rd BioCentury Grand Rounds: U.S.